Palatin Technologies Inc. (PTN)

[Monroe1]

Could have been a ploy, but probably just following the rules of the SEC to distinguish the info from the independent auditor. Nothing was changed or added, just a repeat on a different form.

Shows they are paying attention to detail. How unlike most pennies!
Count ourselves lucky to be holding some shares at this early date.

With top line results being published in near future on completion of Phase 111 we are good to go. Partners will be knocking the door down to distribute the stuff. Bankers/Investors understand new drug designations. Money will be thrown at this company.